Gamida Cell Ltd (GMDAQ)
OTCMKTS: GMDAQ · Delayed Price · USD
0.0160
0.00 (0.00%)
Apr 30, 2024, 12:00 AM EDT - Market closed

Gamida Cell Market Cap

Gamida Cell has a market cap or net worth of $1.76 million as of May 1, 2024. Its market cap has decreased by -96.93% in one year.

Market Cap
1.76M
Enterprise Value
35.09M
1-Year Change
-96.93%
Ranking
n/a
Category
Stock Price
$0.02

Market Cap Chart

Since October 26, 2018, Gamida Cell's market cap has decreased from $156.00M to $1.76M, a decrease of -98.87%. That is a compound annual growth rate of -56.10%.

History

DateMarket Cap% Change
Apr 5, 20245.10M-17.74%
Apr 4, 20246.20M-
Apr 3, 20246.20M-8.82%
Apr 2, 20246.80M19.30%
Apr 1, 20245.70M3.64%
Mar 28, 20245.50M-39.56%
Mar 27, 20249.10M-80.00%
Mar 26, 202445.50M1.56%
Mar 25, 202444.80M-12.67%
Mar 22, 202451.30M-4.11%
Mar 21, 202453.50M7.21%
Mar 20, 202449.90M-3.29%
Mar 19, 202451.60M5.09%
Mar 18, 202449.10M15.80%
Mar 15, 202442.40M-1.62%
Mar 14, 202443.10M-7.51%
Mar 13, 202446.60M12.56%
Mar 12, 202441.40M-8.20%
Mar 11, 202445.10M-0.66%
Mar 8, 202445.40M1.57%
Mar 7, 202444.70M-3.66%
Mar 6, 202446.40M-2.73%
Mar 5, 202447.70M1.49%
Mar 4, 202447.00M-7.48%
Mar 1, 202450.80M6.50%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 700.90B
Novo Nordisk 557.99B
UnitedHealth Group 449.95B
Johnson & Johnson 353.80B
Merck & Co. 329.55B
AbbVie 286.00B
AstraZeneca 233.98B
Thermo Fisher 220.21B
Market Cap Rankings